TipRanks
Advertisement
Advertisement
Cellectis downgraded to Market Perform from Outperform at Citizens
PremiumThe FlyCellectis downgraded to Market Perform from Outperform at Citizens
10d ago
Cellectis Plans Heavy Investor Conference Schedule for Fall 2026
Premium
Company Announcements
Cellectis Plans Heavy Investor Conference Schedule for Fall 2026
23d ago
Cellectis reports Q2 adjusted EPS (35c) vs (40c) last year
Premium
The Fly
Cellectis reports Q2 adjusted EPS (35c) vs (40c) last year
2M ago
Cellectis Shareholders Approve Board-Backed Resolutions at June 25, 2026 Meeting
PremiumCompany AnnouncementsCellectis Shareholders Approve Board-Backed Resolutions at June 25, 2026 Meeting
3M ago
Cellectis Unveils Strong Early CAR-T Data for Lasme-cel and Eti-cel at EHA 2026
Premium
Company Announcements
Cellectis Unveils Strong Early CAR-T Data for Lasme-cel and Eti-cel at EHA 2026
4M ago
Cellectis Gains FDA RMAT Status for Allogeneic CAR-T lasme-cel in r/r B-ALL
Premium
Company Announcements
Cellectis Gains FDA RMAT Status for Allogeneic CAR-T lasme-cel in r/r B-ALL
4M ago
Cellectis to present clinical data on lasme-cel, eti-cel at EHA Congress
PremiumThe FlyCellectis to present clinical data on lasme-cel, eti-cel at EHA Congress
5M ago
Cellectis to Unveil Key Lasme-cel and Eti-cel Data at EHA 2026
Premium
Company Announcements
Cellectis to Unveil Key Lasme-cel and Eti-cel Data at EHA 2026
5M ago
Cellectis reports Q1 adjusted EPS (16c) vs. (17c) last year
Premium
The Fly
Cellectis reports Q1 adjusted EPS (16c) vs. (17c) last year
5M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―